These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37182597)

  • 1. Long-term Visit-to-Visit Variability in Hemoglobin A
    Xu Y; Dong S; Fu EL; Sjölander A; Grams ME; Selvin E; Carrero JJ
    Am J Kidney Dis; 2023 Sep; 82(3):267-278. PubMed ID: 37182597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care.
    Xu Y; Surapaneni A; Alkas J; Evans M; Shin JI; Selvin E; Chang A; Grams ME; Carrero JJ
    Diabetes Care; 2020 Dec; 43(12):2975-2982. PubMed ID: 33023987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.
    Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB;
    Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden.
    Bosi A; Clase CM; Ceriani L; Sjölander A; Fu EL; Runesson B; Chang Z; Landén M; Bellocco R; Elinder CG; Carrero JJ
    JAMA Netw Open; 2023 Jul; 6(7):e2322056. PubMed ID: 37418264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury.
    James MT; Grams ME; Woodward M; Elley CR; Green JA; Wheeler DC; de Jong P; Gansevoort RT; Levey AS; Warnock DG; Sarnak MJ;
    Am J Kidney Dis; 2015 Oct; 66(4):602-12. PubMed ID: 25975964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.
    Wilson M; Packington R; Sewell H; Bartle R; McCole E; Kurth MJ; Richardson C; Shaw S; Akani A; Banks RE; Selby NM
    Am J Kidney Dis; 2022 May; 79(5):646-656.e1. PubMed ID: 34653541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Tarnow L; Jorsal A; Parving HH; Persson F; Hansen TW; Rossing P
    Diabet Med; 2021 May; 38(5):e14459. PubMed ID: 33179275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
    Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
    Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function.
    Takenouchi A; Tsuboi A; Kurata M; Fukuo K; Kazumi T
    J Diabetes Res; 2016; 2016():3295747. PubMed ID: 28090540
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD.
    Allegretti AS; Zhang W; Zhou W; Thurber TK; Rigby SP; Bowman-Stroud C; Trescoli C; Serusclat P; Freeman MW; Halvorsen YC
    Am J Kidney Dis; 2019 Sep; 74(3):328-337. PubMed ID: 31101403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.
    Limkunakul C; de Boer IH; Kestenbaum BR; Himmelfarb J; Ikizler TA; Robinson-Cohen C
    J Diabetes Complications; 2019 Apr; 33(4):296-301. PubMed ID: 30795915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD.
    Heo GY; Koh HB; Kim HW; Park JT; Yoo TH; Kang SW; Kim J; Kim SW; Kim YH; Sung SA; Oh KH; Han SH
    Diabetes Metab J; 2023 Jul; 47(4):535-546. PubMed ID: 37096377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative Acute Kidney Injury Is Associated With Progression of Chronic Kidney Disease Independent of Severity.
    Privratsky JR; Krishnamoorthy V; Raghunathan K; Ohnuma T; Rasouli MR; Long TE; Sigurdsson MI
    Anesth Analg; 2022 Jan; 134(1):49-58. PubMed ID: 34908546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2016 Sep; 13(9):e1002128. PubMed ID: 27648564
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.